• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2011 Fiscal Year Final Research Report

Immune regulation of oral disease by co-signal molecule B7-H3 and the novel receptor.

Research Project

  • PDF
Project/Area Number 21592385
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Pathobiological dentistry/Dental radiology
Research InstitutionDokkyo Medical University (2010-2011)
Tokyo Medical and Dental University (2009)

Principal Investigator

HASHIGUCHI Masaaki  獨協医科大学, 医学部, 免疫学講座 (20372443)

Co-Investigator(Kenkyū-buntansha) AZUMA Miyuki  東京医科歯科大学, 大学院・医歯学総合研究科, 教授 (90255654)
Project Period (FY) 2009 – 2011
Keywords免疫 / 感染 / 炎症
Research Abstract

Co-signal molecules play important roles in positively or negatively regulate cell responses. We previously reported that new cosignal ligand murine B7-H3 and the receptor TLT-2 enhance T cell responses. Here we investigate the precise mechanisms and found, in human system, B7-H3 upregulate T cell responses through the ligation with TLT-2, too. We also clarified TLT-2 upregulates anti-tumor immunity through the enhancement of cytotoxicity by CD8^+T cells. These suggest that B7-H3.TLT-2 enhances anti-tumor immunity and imply that strong or continuous B7-H3.TLT-2 signaling lowers TLT-2.

  • Research Products

    (7 results)

All 2012 2010 2009

All Journal Article (2 results) Presentation (5 results)

  • [Journal Article] Human B7-H3 binds to Triggering receptor expressed on myeloid cell-like transcript 2(TLT-2) and enhances T cell responses. Open J2012

    • Author(s)
      M. Hashiguchi, Y. Inamochi, S. Nagai, S., N. Otsuki, P. Jinhua, H. Kobori, Y. Kanno, T. Kobata, M. Azuma
    • Journal Title

      Immunol. Peer-reviewed

      Volume: 2 Pages: 9-16

    • DOI

      doi:10.4236/oji.2012.21002

  • [Journal Article] Enhancement of effector CD8^+T cell function by tumor-associated B7-H3 and modulation of its counter receptor triggering receptor expressed on myeloid cell-like transcript 2(TLT-2) at tumor sites2010

    • Author(s)
      H. Kobori, M. Hashiguchi, J. Piao, M. Kato, P. Ritprajak, M. Azuma
    • Journal Title

      Immunology Peer-reviewed

      Volume: 130 Pages: 363-373

    • DOI

      doi:10.1111/j.1365-2567.2009.03236.x

  • [Presentation] Enhancement of effector CD8^+T cell function by tumor-associated B7-H3 and modulation of its counter receptor triggering receptor expressed on myeloid cell-like transcript 2(TLT-2) at tumor sites2010

    • Author(s)
      H. Kobori, M Hashiguchi, M. Azuma
    • Organizer
      14th International Congress of Immunology
    • Place of Presentation
      Kobe, Japan
    • Year and Date
      2010-08-26
  • [Presentation] Triggering receptor expressed on myeloid cells-like transcript 2(TLT-2) is a counter-receptor for B7-H3 and enhances T cell responses in mice and humans2010

    • Author(s)
      M. Hashiguchi, H. Kobori, P. Ritprajak, Y. Kamimura, M. Azuma
    • Organizer
      14th International Congress of Immunology
    • Place of Presentation
      Kobe, Japan
    • Year and Date
      2010-08-26
  • [Presentation] Binding property, expression, and function of human TLT2, a counter-receptor for B7-H32009

    • Author(s)
      M. Hashiguchi, H. Kobori, M. Azuma
    • Organizer
      日本免疫学会学術集会
    • Place of Presentation
      大阪
    • Year and Date
      2009-12-03
  • [Presentation] Tumor-infiltrating CD8^+T cells express TLT-2, a counter receptor for B7-H3 and B7-H3-transduced tumors preferentially augment effector function of CD8^+T cells2009

    • Author(s)
      H. Kobori, M. Hashiguchi, M. Azuma
    • Organizer
      日本免疫学会学術集会
    • Place of Presentation
      大阪
    • Year and Date
      2009-12-03
  • [Presentation] Analyses of anti-tumor immunity enhanced by a B7-H3 costimulator2009

    • Author(s)
      H. Kobori, M. Hashiguchi, M. Azuma
    • Organizer
      日本癌学会学術集会
    • Place of Presentation
      横浜
    • Year and Date
      2009-10-02

URL: 

Published: 2013-07-31  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi